chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very strong dizziness; stomachache pain; Fever; Trowed up; Headache; weakness; Eyes pain; Pain; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 23Apr2021 at 16:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. On 23Apr2021 at 15:45, the patient experienced very strong dizziness, stomach-ache, pain, fever, trowed up (vomit), headache, weakness and eyes pain. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very strong dizziness, stomach-ache, pain, fever, trowed up (vomit), headache, weakness and eyes pain were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
NAUSEOUS FEELING; SEVERE BODY ACHES; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 14-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, the subject experienced severe body aches. On 17-MAY-2021, the subject experienced nauseous feeling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from severe body aches, and the outcome of nauseous feeling was not reported. This report was non-serious.
Tenderness and aching at injection site, feels bruised by no sign of bruising, swollen. Feels like punched in arm. Treatment includes ice and ibuprofen. Pain continues.
Sinuses hurting; This spontaneous case was reported by a consumer and describes the occurrence of SINUS PAIN (Sinuses hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced SINUS PAIN (Sinuses hurting). At the time of the report, SINUS PAIN (Sinuses hurting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, SARS-CoV-2 test: positive (Positive) Positive.         No Concomitant medication was reported No treatment Drug was reported
Received a second Bivalent  booster within 3 months of 1st Bivalent booster.
This spontaneous report as received from a 54 year old male consumer refers himself. The patient's medical history included lumbar fusion and knee replacement. His current condition included allergy to sulphur. On 27-DEC-2016, the patient was vaccinated with ZOSTAVAX (dose, lot number and expiry date were not reported), intravenous for prophylaxis. There were no concomitant medications. On 27-DEC-2016, the patient experienced slight lightheadedness (dizziness). On an unknown date, the patient got his yearly physical (blood work) done. The outcome of dizziness was unknown. The causality was not reported. Additional information has been requested.
Nausea 15 minutes after receiving the vaccine on Dec. 7, 2021.   Vomiting and nausea has continued thru today 12-13-21.  Sharp muscle pains in hands-unable to sleep due to pain
I ate eggs which I?ve always eaten with No issues- and it caused throat constriction, both of my arms to break out in massive hives (I have photos), slurred speech, heart palpitations, muscle weakness, and diarrhea . I now can?t have eggs and more nut proteins like almonds and hazelnuts are now sensitive, when I was eating almond butter by the jar in December. Nothing is changed but the fact I got the Flu vaccine required for me to volunteer in the hospital.
fever; she had chills; headache for 24 hours; This case was reported by a consumer via call center representative and described the occurrence of chills in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced chills, headache and fever. On an unknown date, the outcome of the chills and headache were recovered/resolved and the outcome of the fever was unknown.   It was unknown if the reporter considered the chills, headache and fever to be related to Shingrix.  Additional details were provided as follows: The case was reported by the friend of the patient. The age at vaccination was not reported. Patient received Shingrix vaccine and experienced chills, fever and headache for 24 hours. The reporter refused to provide any other details other than what was reported in this report. The reporter did not consent to follow up. This case is one of the 5 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021097925:Same reporter US-GLAXOSMITHKLINE-US2021AMR099471:Same reporter US-GLAXOSMITHKLINE-US2021097926:Same reporter US-GLAXOSMITHKLINE-US2021AMR099469:Same reporter US-GLAXOSMITHKLINE-US2021AMR099470:Same reporter
The Moderna vaccine was given to 6-10 people after the vial had been punctured and stored over a four day weekend.
four or five days later the psoriasis had disappered; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that 62-year-old female patient received he her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 06Apr2021 at single dose for COVID-19 immunisation. Medical history included psoriasis and pre diabetic. The patient's concomitant medications were not reported. The patient had psoriasis didn't take any medication for it and was pre diabetic. She received her first vaccine on April 6th and four or five days later the psoriasis had disappeared in Apr2021. AE due to psoriasis clearing up after first vaccine. The outcome of event was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
PATIENT HAS HAD TO MAKE SEVERAL TRIPS TO THE DOCTOR'S OFFICE DUE TO MUSCLE WEAKNESS.
Around 4pm 5/17: elevated heart rate/pumping/racing heart and anxiety   Around 1am 5/18: racing heart and difficulty breathing (around 100bpm while resting
Child and parent noted irregular area of moderate erythema and induration surrounding vaccination site. Minimal pain with palpation. No itching. No pruritis.
Feels like she is going to pass out. Evaluated by EMS-Refusal to transport.
Redness & inflammation (1/2 inch) that occurred adjacent to injection site 1 week & 2 day post vaccination. Area of redness/swelling continues to increase in diameter (2" in diameter).
24 hours after IMM's developed rash with fever, generalized erythema, 1 papula left neck no itch no pain no burning no hives. temp 100.5
This is a spontaneous report from a contactable healthcare professional. A 17-year-old patient of unspecified gender received the first single dose of TRUMENBA on an unspecified date, for immunization. Medical history and concomitant medications were not reported. On an unspecified date the patient experienced pain and swelling for 1 week. The events resolved on an unspecified date.   The reporter understood these events were expected.
It started with muscle aches and hip joint soreness, by january 2010 my back and neck started hurting along with with my hip, then the pain at night increased along with some periods of relief.  This pain of neck mid back  and hip pain came and went  with pain times getting longer and fatigue setting in.  I went to the Dr. June 27, 2010 and Dr. did some testing with a result of rheumatoid arthritis  with NO family history present.  I have started celebrex and have contacted a rheumatologist for subsequent appointments.
labored breathing, horse cough, tight chest;wheezing 9/2/99;runny nose 8/29/99;tired, crying;8/26/99 swollen, warm rt arm;
Chills, body ache, sleepy, not sleepy, 2 days after 2nd shot. First shot i felt like death would be better.
This case was reported by a nurse and described the occurrence of injection site mass in a 31 year old female pt who had received Engerix-B for prophylaxis. In 1/04, the pt received the 2nd dose of Engerix-B. Approximately 1 month after immunization, on 2/23/04, the pt developed injection site mass. She was examined by her physician who stated that the mass looked like a seroma. The event was unresolved at the time of reporting. The nurse considered the events were probably related to vaccination with Engerix-B.
Lyme disease; Diagnosed with alopecia areata; Loss of hair on his head; Loss of eye lashes/losing of eyelashes/Loss of his eyebrows; This spontaneous case was reported by a consumer and describes the occurrence of LYME DISEASE (Lyme disease) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Environmental allergy (takes allergy shot for his allergy and uses inhaler) and Asthma.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In May 2021, the patient experienced ALOPECIA (Loss of hair on his head) and MADAROSIS (Loss of eye lashes/losing of eyelashes/Loss of his eyebrows). On an unknown date, the patient experienced LYME DISEASE (Lyme disease) (seriousness criterion medically significant) and ALOPECIA AREATA (Diagnosed with alopecia areata). The patient was treated with MINOXIDIL (ROGAINE) (oral) for Ingrown hair, at an unspecified dose and frequency. At the time of the report, LYME DISEASE (Lyme disease), ALOPECIA (Loss of hair on his head), MADAROSIS (Loss of eye lashes/losing of eyelashes/Loss of his eyebrows) and ALOPECIA AREATA (Diagnosed with alopecia areata) outcome was unknown.            Concomitant medications included allergy shot for his allergy and uses inhaler.  On May-2021, the patient started losing his eyes lashes, the hair on his head and his eyebrows. He went to the dermatologist; he was diagnosed with alopecia areata. Patient was currently getting steroid shot at the dermatologist office and was previously on oral rogaine to regrow his hair but had to stop because it was dropping his blood pressure.   The patient recently got a tick bite, so he was also dealing with lyme disease now.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient was walking around the pharmacy approximately 10 minutes after receiving her first COVID vaccine where she felt lightheaded and passed out into a shelf. By the time pharmacist and technician were with the patient, the patient was awake and oriented. Offered to call 911, both patient and mother refused. Gave patient a Gatorade and a chair to relax before leaving the store.  Patient was able to walk out on her own and felt fine.
Dizziness Shaking chills Fever Strong headache) Body pain A lot of pain in the arm from the injection. (redness) Asthma
Information has been received from a nurse via a company representative referring to a 18 years old male patient. Pertinent medical history and drug reactions/allergies were not reported. On an unknown date the patient was vaccinated with GARDASIL 9 (dose, route, lot# and expiration date were not reported) (drug administration error). Concomitant drug was not reported. The patient experienced soreness in his arm and couldn't move his arm after receiving vaccination with GARDASIL 9. The outcome of the events and the causality were unknown. This is one of two reports received from the same reporter. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; Vaccine brand: Pfizer / BioNTech; Vaccine dose number: 4/ Vaccine brand other: Moderna; Vaccine dose number: 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 67-year-old male patient received BNT162b2 (BNT162B2), on 04May2022 as dose 4 (booster), single (Lot number: FK9893), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 15Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 17Feb2021 as dose 2, single (Lot number: 006M20A), in left arm and on 17Sep2021 as dose 3 (booster), single (Lot number: 048F21A), in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: EZETIMIBE, start date: Aug2021, stop date: Sep2022; LISINOPRIL, start date: Jan2018, stop date: Sep2022; ROSUVASTATIN, start date: Mar2017, stop date: 19Aug2022. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 04May2022, outcome "unknown", described as "Vaccine brand: Pfizer / BioNTech; Vaccine dose number: 4/ Vaccine brand other: Moderna; Vaccine dose number: 3"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: Tested positive on antigen test; (unspecified date) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient was received Paxlovid for Covid -19 treatment from 19Aug2022 to 23Aug2022. The  Covid rebound 13 days after starting paxlovid. Tested positive on antigen test and was symptomatic for 3 days. The patient don't have any known allergies.  No follow-up attempts are possible. No further information is expected.
death N17.9 - Acute renal failure, unspecified acute renal failure type
My son came home in a panic. He was upset that his right shoulder was itching, red, and swollen. He said the skin in on his shoulder felt tight, hot, and sore. He described the itching as intense, the redness was pronounced, and his shoulder was noticeably puffy and larger than normal.
Information has been received from a medical assistant concerning a 42-month-old female patient who on 02-JUL-2003 was vaccinated with a dose of varicella virus vaccine live.  On approximately 28-DEC-2005, the patient developed chickenpox.  Unspecified medical attention was sought.  There was no product quality complaint involved.  No further information was available.  Additional information has been requested.
got the shot and had shingles afterwards/suspected vaccination failure; Shingles; mild case, hurt anyway; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.  It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient got the shot and had shingles afterwards. The patient stated that the doctor said because of the shot it was a mild case. The patient stated it hurt anyway. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available
This spontaneous report was received from a pharmacist , concerning a 1 year old female patient. The patient's concurrent conditions and pertinent medical history were not mentioned. On 28-APR-2017, the patient was vaccinated with VAQTA 25/0.5 (units not provided) 2 doses, given intramuscularly, which had lot # N005605 with expiry date on 08-APR-2018 prophylaxis. Concomitant therapies included PROQUAD. The reporting pharmacist stated that the patient received an adult dose and some of the vaccine leaked out of thigh; the patient experienced an overdose; however no adverse effects were noted. She did not seek medical attention and no product quality complaint was involved. Additional information has been requested.
Left upper/outer arm (overlying deltoid) began having redness, heat and mild swelling within 24 hrs of receiving DTaP 5th dose, IPV fourth dose at that site. No fever or systemic symptoms. Zone of erythema approximately 8cm x 5cm. No further progression. Examined approximately 48 hrs after vaccination. Local care only, ibuprofen po.
52-year-old female with shortness of breath, cough, sore throat,  Headache, and chest pressure today. She received her 2nd COVID vaccine yesterday. She has a h/o HTN, HLD, CHF, s/p MVR 2017, Vertigo and anemia.  She did not have the symptoms with the first dose.  She denies any fever/chills, she does have generalized body aches with frontal headache that is not worse headache of her life or thunderclap in nature, it is aching, no associated neurological deficit.  No blood thinner use.  She does have a productive cough of clear sputum, sore throat w/o trismus, drooling, tripod or voice change. No meningismus. She has chest wall pain with tightness and Dyspnea with exertion. No wheezing or hemoptysis.  No radiating or pleuritic chest pain, palpitations, orthopnea, diaphoresis, N/V, or extremity edema.
I passed out while out at night (I do not drink/smoke/do drugs) which led to a neurologist visit.  There they found activity in the brain (where vaccinations also go to) which was called "migraines" or minor seizure activity.  This led to medication to be taken daily.  Stomach issues (that were minor) then progressed over the next year, could then not tolerate/digest food which was found to be a rare condition called celiac artery compression syndrome and major surgery.  From there I had many complications and the doctors are still figuring out what it may be.  I also was diagnosed with celiacs disease.  As of two days ago, even with the Gardasil shot, I was told I have HPV and am waiting on biopsy results.  I went from a perfectly healthy, active 23 year old, to one that's life has been stopped due to doctors visits and sickness, which I attribute to the Gardasil shot.
Received DTaP in antr right thigh 07/03/02. 07/04/02 redness and swelling noted at site w/o pain or immp, increasing redness noted so seen 07/05/02 w/ 9x5.5cm redness with induration. No pain.
P/immun given mom gave pt APAP, pt vomited & then fell asleep; felt warm to touch (temp not measured); devel episode of shaking, turned purple, had dyspnea then breathing stopped for several seconds; pt taken to ER t105 R; less active; UTI
numb tongue for 9 hours and fatigue, heart palpitations for 2 days.
Narrative: Patient had COVID (Moderna) vacc #1 on 2/8/2021 and about 7-10 days later started having left leg swelling and pain. He ignored it for about 2 weeks, then presented to ER for this. He was diagnosed with left leg DVT and had thrombectomy, started on Xarelto 15 mg bid by hospital. Patient did  come back to facility for 2nd COVID (Moderna) vaccine 3/9/21, however, since was on the Xarelto loading dose, would not expect recurrent or more clotting and could not correlate any clotting to the 2nd COVID vaccine
Please see attached report -. HPV #2 (lot # H009746 with exp. date 11JAN15) vaccine was administered at 10:25 per MD order. There was immediate bleeding lasting less than 5 seconds upon removal of the needle. Bleeding was stopped with compression. A quarter sized hematoma was noted at the vaccine site with redness spreading t half dollar size. Patient complained of soreness and numbness all over her left arm at 10:30am. MD was notified and ordered a cold compression dressing and 400mg of ibuprofen, which was administered orally at 10:35 am. Patient began itching all over left arm at 10:45 am. BENADRYL 25 mg was given orally at 10:47 am per MD order. At 11:32am, a pressure dressing was applied and the cold pack was removed per MD order. The patient was released from our care in good condition. Mother and patient were instructed to continue 400mg of ibuprofen every six hours for the next 48 hours. Mother was advised of the possibility of bruising and swelling. Patient was instructed to follow up with any concerns.
Patient received Pfizer COVID vaccine on 2/12/21 and 3/9/21. On 2/28/23, patient admitted to our inpatient facility (med/surg unit) with acute hypoxic respiratory failure secondary to acute CHF and COVID-19 pneumonia. Patient discharged home on 3/6/23.
SEVERE SWELLING IN RIGHT THIGH, SAME PLACE WHERE VACCINE WAS ADMINISTERED.
Client was present in the clinic for her booster dose of Pfizer (LOT FK9894-A). There was an attempt to deliver the dose to the client?s left arm, but the needle became disconnected form the syringe during the vaccination and the client received less than half a dose. The vaccinator, LPN, reported the occurrence to the clinical site supervisor RN PHSS and the pharmacist (the clinician who had originally prepared the dose). The client and her guardian were made aware and the opposite arm was vaccinated at 1706 per protocol.
Flu shot made me very ill; This case was reported by a consumer via call center representative and described the occurrence of malaise in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Concomitant products included fluticasone propionate (Flonase).   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season and an unknown time after starting Flonase, the patient experienced malaise. On an unknown date, the outcome of the malaise was unknown.   It was unknown if the reporter considered the malaise to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were reported as follows: The age at vaccination was not reported. The patient received flu shot and was very ill after vaccination. The patient was currently on Flonase drug which kept patient breathing healthily. No other inforamtion was repoted. This case has been linked with US2020078871, reported by same reporter.
1 of 2 children recvd vax & exp an adverse event;pt cried unconsolably;given APAP;pt recovered;duration of event unk
Patient displayed symptoms to syncope after receiving the vaccine. Patient regained consciousness within 10 seconds after passing out. Patient's mother and I monitored patient for about 35 minutes after regaining consciousness.
Hallucinations, Myalgia, fatigue, light headedness Narrative:  Other Relevant History: